Diabetes stories
Ottai's low-cost continuous glucose monitor wins 1 million users as the China-based maker expands into Malaysia and Australia.
Salesforce has rolled out Agentforce 2dx, a cutting-edge digital labour platform that integrates AI agents into business workflows for enhanced efficiency.
AI agents are set to transform daily life across sectors, optimising everything from smart homes to personalised shopping, according to Raphael Allstadt.
The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.
The healthcare sector is on the brink of transformation as experts predict the AI market could reach USD $17.2 billion by 2032, revolutionising patient care.
Iktos and Cube Biotech have partnered to leverage AI-driven drug discovery and advanced protein technology, targeting the Amylin Receptor for cardiometabolic disorders.
A report reveals ongoing financial strain for Australians and New Zealanders, with rising living costs leaving nearly half feeling worse off than last year.
The gamified healthcare app market is predicted to soar to USD $31 billion by 2034, bolstered by rising chronic disease incidences.
Canada deepens life sciences push with CAD $127m for Vancouver projects as Aspect Biosystems and Providence Health Care expand biomanufacturing and trials.
Abbott's new glucose monitor promises a discreet upgrade for diabetics, with smartphone readings, 15-day wear and pump integration in Australia.
Zoom Health is urging an overhaul of New Zealand's pharmacy funding as 12‑month prescriptions loom, warning closures and care gaps will grow.
New Zealand's employee health plan costs are set to surge 18% in 2026, far exceeding the Asia Pacific and global averages amid rising healthcare demands.
Sol Menopause launches its app in Asia, offering medically reviewed support to women and employers for menopause health and inclusive workplaces.
Australians with diabetes can now monitor glucose levels and receive alerts directly on their Apple Watch through new Dexcom G7 integration.
Dexcom's latest innovation, the ONE+, is set to transform diabetes management in Australia by offering real-time glucose monitoring and alerts for Type 2 diabetes.
AI diagnostics is transforming healthcare by enhancing accuracy, speeding up disease detection, and reducing errors across lab tests, imaging, and genomics.
Dexcom has launched its Dexcom ONE+ continuous glucose monitoring system in Australia, enhancing glucose management for those with Type 2 diabetes.
Australians travelling this holiday season can now manage their health with new features on the my health app, enhancing access to vital information.
Ransomware tactics have evolved significantly, prompting Australian organisations to focus on midgame detection to counteract increasing cyber threats.
Dexcom has rolled out its advanced Dexcom G7 glucose monitoring system in Australia, featuring rapid sensor activation, no fingerpricks, and improved connectivity.
